Advertisement
UCB SA

UCB SA (UCBJY) Stock Overview

Explore UCB SA’s financial performance, market position, analyst ratings, and future outlook.

UCBJYPNK
HealthcareBiotechnology
$151.73
$0.08(0.05%)
U.S. Market opens in 7h 22m
Advertisement

UCB SA (UCBJY)

Meyka AI Score

Z

Key Financials

Market Cap57.8B
P/E Ratio32.26
EPS (TTM)$4.62
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$125.82
3 Months$158.02
1 Year Target$179.52

UCBJY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of UCB SA (UCBJY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $179.52.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.26 and a market capitalization of 57.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.05%
5-Day Change
0.30%
1-Month Change
9.79%
3-Month Change
-0.15%
6-Month Change
6.63%
Year-to-Date (YTD) Change
8.56%
1-Year Change
60.85%
3-Year Change
232.23%
5-Year Change
202.25%
All-Time (Max) Change
911.53%

Contact Information

32 2 559 99 99
Allée de la Recherche, 60, Brussels, NaN, 1070

Company Facts

9,052 Employees
IPO DateAug 3, 2012
CountryBE
Actively Trading

Frequently Asked Questions